InVivo Therapeutics (NASDAQ:NVIV – Get Rating) and InspireMD (NYSE:NSPR – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Risk & Volatility InVivo Therapeutics has a beta of 1.26, […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a note issued to investors on Monday. The firm set a “sell” rating on the biotechnology company’s stock. Shares of NASDAQ NVIV opened at $4.89 on Monday. The stock has a market cap of $6.80 million, a PE ratio of -0.64 and […]
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a report released on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. NASDAQ NVIV opened at $4.54 on Friday. The business’s fifty day moving average is $6.68 and its 200 day moving average is $9.91. InVivo Therapeutics has […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a research note issued on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. InVivo Therapeutics stock opened at $0.23 on Wednesday. InVivo Therapeutics has a 1-year low of $0.20 and a 1-year high of $0.93. The firm’s fifty […]
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a report issued on Friday. The firm issued a sell rating on the biotechnology company’s stock. NASDAQ NVIV opened at $0.36 on Friday. InVivo Therapeutics has a twelve month low of $0.26 and a twelve month high of $1.15. The business’s fifty […]